Abuse and misuse potential of drugs for attention deficit/hyperactivity disorder: a review of the clinical evidence
CADTH
Record ID 32014000097
English
Authors' recommendations:
No conclusions can be drawn regarding the abuse potential of atomoxetine due to the limited data available. Misuse of methylphenidate and amphetamine-based ADHD drugs was found in adolescent and young adult population, particularly among undergraduate university students. Misuse of ADHD stimulants also occurred in non-institutionalized adults. The prevalence of stimulant misuse among studies ranged from 5% to 35% in adults and from 5% to 12% in adolescents. There was evidence for potential diversion of stimulant ADHD medication from individuals with prescriptions to individuals without prescriptions.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/aug-2013/RC472%20Abuse%20and%20misuse%20potential%20of%20drugs%20for%20ADHD%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Risk-Taking
- Substance-Related Disorders
- Attention Deficit Disorder with Hyperactivity
- Central Nervous System Stimulants
- Self Medication
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.